Latanoprost 50 micrograms/ml Eye drops solution

国: アイルランド

言語: 英語

ソース: HPRA (Health Products Regulatory Authority)

有効成分:

Latanoprost

から入手可能:

Cipla (EU) Limited

ATCコード:

S01EE01

INN（国際名）:

Latanoprost

投薬量:

50 micrograms/ml

医薬品形態:

Eye drops, solution

投与経路:

Eye instillation

パッケージ内のユニット:

Pack sizes: 1 x 2.5 ml, 3 x 2.5 ml, 6 x 2.5 ml

処方タイプ:

Product subject to prescription which may not be renewed (A)

製:

S&D Pharma CZ

治療群:

Antiglaucoma preparations and miotics, prostaglandin analogues

適応症:

It in indicated for reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension. in paediatric patients with elevated intraocular pressure and paediatric glaucoma

認証ステータス:

Authorised

承認日:

2015-07-24

情報リーフレット

PACKAGE LEAFLET: INFORMATION FOR THE USER
LATANOPROST 50 MICROGRAMS/ML EYE DROPS, SOLUTION
LATANOPROST
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
-  Keep this leaflet. You may need to read it again.
-  If you have any further questions, ask your or your child’s
doctor or pharmacist.
-  This medicine has been prescribed for you or for your child. Do
not pass it on to others. It may harm them, even if their signs of
illness are 
the same as yours.
-  If you get any side effects, talk to your or your child’s
doctoror pharmacist. This includes any possible side effects not
listed in this leaflet. 
See section 4.

WHAT IS IN THIS LEAFLET:

1. What latanoprost eye drops are and what it is  used for

2. What you need to know before you use latanoprost eye drops

3. How to use latanoprost eye drops

4. Possible side effects

5. How to store latanoprost eye drops

6. Contents of the pack and other information
   1.  WHAT LATANOPROST EYE DROPS ARE AND WHAT IT IS USED FOR
Latanoprost belongs to a group of medicines known as prostaglandin
analogues. It works by increasing the natural outflow of fluid from 
inside the eye into the bloodstream.
Latanoprost contains the active substance Latanoprost 0.005% w/v (50
micrograms per ml) eye drops solution.
Latanoprost is used to treat conditions known as open angle glaucoma
and ocular hypertension. Both of these conditions are linked with an 
increase in the pressure within your eye, eventually affecting your
eye sight.
Latanoprost is also used to treat increased eye pressure and glaucoma
in all ages of children and babies.

2.  WHAT YOU NEED TO KNOW BEFORE YOU USE LATANOPROST EYE DROPS
Latanoprost can be used in adult men and women (including the elderly)
and in children from birth to 18 years of age. Latanoprost has not 
been investigated in prematurely born infants (less than 36 weeks
gestation).
DO NOT USE LATANOPROST EYE DROPS
-  if you are ALLER

製品の特徴

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Latanoprost 50 micrograms/ml Eye drops solution.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1ml eye drops solution contains 50 micrograms latanoprost.
One drop contains approximately 1.5 micrograms latanoprost.
Excipient with known effects:
Benzalkonium chloride 0.02% w/v (0.21mg/ml) is included as a preservative.
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Eye drops, solution.
Clear, colourless solution practically free from particles filled in 5 ml FFS vial.
pH: 6.40-7.00
Osmolality: 240-300 mOsmols / kg
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Latanoprost in indicated for reduction of elevated intraocular pressure
in patients with open angle glaucoma and ocular hypertension.
in paediatric patients with elevated intraocular pressure and paediatric glaucoma.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Recommended dosage for adults (including the elderly):_
Recommended therapy is one eye drop in the affected eye(s) once daily. Optimal effect is obtained if Latanoprost eye
drops is administered in the evening.
The dosage of Latanoprost eye drops should not exceed once daily since it has been shown that more frequent
administration decreases the intraocular pressure lowering effect.
If one dose is missed, treatment should continue with the next dose as normal.
As with any eye drops, to reduce possible systemic absorption, it is recommended that the lachrymal sac is compressed
at the medial canthus (punctal occlusion) for one minute. This should be performed immediately following the
instillation of each drop.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 27/07/2015_
_CRN 214154